WAVRE, Belgium — 10 July 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial for the MINIjectTM device in a standalone setting. These results confirm the stability and sustained performance of MINIject beyond the first […]
WAVRE, Belgium — 19 December 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional one-year results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial, for the MINIjectTM device in a standalone setting. Results continue to show that MINIject is safe and highly effective in […]
WAVRE, Belgium — 16 May 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional six-month results of their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device in a standalone setting. Results show MINIject to be safe and highly effective in achieving significant […]
Novel MINIject device made from STAR® material successfully implanted in 25 patients WAVRE, Belgium — 17 October 2017: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the completion of enrolment in their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device.
Martin Wax, M.D. and Marc Nolet de Brauwere appointed to Board of Directors WAVRE, Belgium — 28 June 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors. Dr […]
/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.png00admin/wp-content/uploads/2016/05/Logo-Istar-CMJN-300x138.pngadmin2016-06-28 17:19:112017-10-17 08:01:29iSTAR Medical Strengthens Board with Two Senior Appointments
iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)
/in Press Releases /by Katherin AwadWAVRE, Belgium — 10 July 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial for the MINIjectTM device in a standalone setting. These results confirm the stability and sustained performance of MINIject beyond the first […]
iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)
/in Press Releases /by Katherin AwadWAVRE, Belgium — 19 December 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional one-year results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial, for the MINIjectTM device in a standalone setting. Results continue to show that MINIject is safe and highly effective in […]
iSTAR Medical’s MINIject delivers exceptional 6-month results in first-in-human trial
/in Press Releases /by Katherin AwadWAVRE, Belgium — 16 May 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional six-month results of their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device in a standalone setting. Results show MINIject to be safe and highly effective in achieving significant […]
iSTAR Medical completes enrolment of first-in-human MIGS trial
/in Press Releases /by Katherin AwadNovel MINIject device made from STAR® material successfully implanted in 25 patients WAVRE, Belgium — 17 October 2017: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the completion of enrolment in their first-in-human (FIH) micro-invasive glaucoma surgery (MIGS) trial for the MINIjectTM device.
iSTAR Medical Strengthens Board with Two Senior Appointments
/in Press Releases /by adminMartin Wax, M.D. and Marc Nolet de Brauwere appointed to Board of Directors WAVRE, Belgium — 28 June 2016: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, announced today the appointment of Martin Wax, M.D. and Marc Nolet de Brauwere to the Board of Directors. Dr […]